Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial

Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial

Bibliographic Details
Main Authors:	Lundby-Christensen, Louise, Vaag, Allan, Tarnow, Lise, Almdal, Thomas P, Lund, Søren S, Wetterslev, Jørn, Gluud, Christian, Boesgaard, Trine W, Wiinberg, Niels, Perrild, Hans, Krarup, Thure, Snorgaard, Ole, Gade-Rasmussen, Birthe, Thorsteinsson, Birger, Røder, Michael, Mathiesen, Elisabeth R, Jensen, Tonny, Vestergaard, Henrik, Hedetoft, Christoffer, Breum, Leif, Duun, Elsebeth, Sneppen, Simone B, Pedersen, Oluf, Hemmingsen, Bianca, Carstensen, Bendix, Madsbad, Sten
Format:	Online
Language:	English
Published:	BMJ Publishing Group 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771974/

Similar Items

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
by: Lundby-Christensen, Louise, et al.
Published: (2016)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
by: Nasrallah, Sami N., et al.
Published: (2012)

Concentrated insulins: the new basal insulins
by: Lamos, Elizabeth M, et al.
Published: (2016)

Future of newer basal insulin
by: Madhu, S. V., et al.
Published: (2013)

Cardiovascular effects of basal insulins
by: Mannucci, Edoardo, et al.
Published: (2015)

Degludec insulin: A novel basal insulin
by: Kalra, Sanjay, et al.
Published: (2011)

Vitamin D, carotid intima–media thickness and bone structure in patients with type 2 diabetes
by: Winckler, Karoline, et al.
Published: (2015)

Lixisenatide as add-on therapy to basal insulin
by: Brown, Dominique Xavier, et al.
Published: (2013)

Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues
by: Vaag, Allan, et al.
Published: (2012)

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
by: Hemmingsen, Bianca, et al.
Published: (2011)

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
by: Rodrigo Oliveira Moreira, et al.
Published: (2018-04-01)

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
by: Kristensen, Peter Lommer, et al.
Published: (2012)

Predicting the Optimal Basal Insulin Infusion Pattern in Children and Adolescents on Insulin Pumps
by: Holterhus, Paul-Martin, et al.
Published: (2013)

Insulin Degludec: A Significant Advancement in Ultralong-Acting Basal Insulin
by: Kalra, Sanjay
Published: (2013)

The metabolic and mitogenic properties of basal insulin analogues
by: Tennagels, Norbert, et al.
Published: (2013)

Basal Insulin Use With GLP-1 Receptor Agonists
by: Anderson, Sarah L., et al.
Published: (2016)

Concepts and clinical use of ultra-long basal insulin
by: Eliaschewitz, Freddy Goldberg, et al.
Published: (2016)

Modern basal insulin analogs: An incomplete story
by: Singh, Awadhesh Kumar, et al.
Published: (2014)

THERAPY OF ENDOCRINE DISEASE: Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues
by: Vaag, Allan, et al.
Published: (2012)

Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials
by: Kähler, Pernille, et al.
Published: (2014)

Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
by: Pfohl, Martin, et al.
Published: (2015)

Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A1 chieve study
by: Bhattacharyya, Arpandev, et al.
Published: (2014)

Basal Insulin Requirement Is ∼30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients Who Use the Insulin Pump
by: Kuroda, Akio, et al.
Published: (2011)

Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial
by: Davies, M. J., et al.
Published: (2016)

The role of sulfonylurea plus basal insulin on glycemic variability compared to basal bolus regime in T2D patients
by: Freire, Paula Vieira, et al.
Published: (2015)

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes
by: Bergenstal, Richard M., et al.
Published: (2012)

Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
by: Tosaka, Yuka, et al.
Published: (2015)

Melatonin modifies basal and stimulated insulin secretion via NADPH oxidase
by: Simões, D., et al.
Published: (2016)

Effect of ficus deltoidea extracts on hepatic basal and insulin-stimulated glucose uptake
by: Adam, Z., et al.
Published: (2009)

Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs
by: Poon, Kitty, et al.
Published: (2010)

Detemir as a once-daily basal insulin in type 2 diabetes
by: Nelson, Scott E
Published: (2011)

Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
by: Ahmann, Andrew
Published: (2015)

Basal insulin requirement of youth with type 1 diabetes differs according to age
by: Urakami, Tatsuhiko, et al.
Published: (2013)

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring
by: Abe, Shinya, et al.
Published: (2011)

Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes
by: Riddle, Matthew, et al.
Published: (2009)

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
by: TSAI, Shih-Tzer, et al.
Published: (2011)

Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
by: Wang, Fei, et al.
Published: (2012)

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
by: Jonassen, Ib, et al.
Published: (2012)

In search of the ideal basal insulin: Does the new‐generation ultra‐long‐acting insulin, degludec, provide the answer?
by: Hui, Elaine, et al.
Published: (2013)

Insulin glargine versus other types of basal insulin–clinical and tumor characteristics in patients with breast carcinoma
by: Besic, Nikola, et al.
Published: (2013)